Price (delayed)
$2.98
Market cap
$52.26M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.27
Enterprise value
$51.57M
Hancock Jaffe Laboratories specializes in developing and manufacturing bioprosthetic (tissue-based) medical devices to establish improved standards of care for treating cardiac and vascular diseases. HJLI currently has two lead product
There are no recent dividends present for NVNO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.